دورية أكاديمية

Short-Term Effects of Whole-Body Photobiomodulation on Pain, Quality of Life and Psychological Factors in a Population Suffering from Fibromyalgia: A Triple-Blinded Randomised Clinical Trial.

التفاصيل البيبلوغرافية
العنوان: Short-Term Effects of Whole-Body Photobiomodulation on Pain, Quality of Life and Psychological Factors in a Population Suffering from Fibromyalgia: A Triple-Blinded Randomised Clinical Trial.
المؤلفون: Navarro-Ledesma S; Department of Physiotherapy, Faculty of Health Sciences, University of Granada, Querol Street, 5, 52004, Melilla, Spain. snl@ugr.es., Carroll J; THOR Photomedicine Ltd., Amersham, UK., Burton P; THOR Photomedicine Ltd., Amersham, UK., Ana GM; Clínica Ana González, Malaga, Spain.
المصدر: Pain and therapy [Pain Ther] 2023 Feb; Vol. 12 (1), pp. 225-239. Date of Electronic Publication: 2022 Nov 11.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Adis Country of Publication: New Zealand NLM ID: 101634491 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8237 (Print) NLM ISO Abbreviation: Pain Ther Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: 2014- : [Auckland] Adis
Original Publication: [London] : Springer Healthcare
مستخلص: Background: Fibromyalgia (FM) is a multifunctional chronic musculoskeletal pain condition characterised by sensory hypersensitivity. Photobiomodulation (PBM) has shown a positive impact on relieving pain; however, no studies to our knowledge have analysed a whole-body PBM intervention in subjects with FM. The aims of the study were to compare the effects of whole-body PBM with placebo PBM on pain, functionality and psychological symptoms in patients suffering from FM.
Methods: Forty-two subjects were recruited from a private care practice. The design of the study is a randomised, triple-blinded, placebo-controlled clinical trial. Participants received 12 treatment sessions. Pain, quality of life, level of physical activity and psychological factors were assessed at baseline (T0), after session 6 (T1), after treatment (T2) and at 2-week (T3) follow-up.
Results: There were statistically significant differences in pain at 4 weeks (p ≤ 0.001) (T2) and the 2-week follow-up (T3) (p ≤ 0.001). In relation to the quality of life, there were statistically significant improvements after session 6 (p ≤ 0.001) (T1), immediately after treatment (p ≤ 0.001) (T2) and at the 2-week (T3) follow-up (p ≤ 0.001). Kinesiophobia presented significant differences between groups immediately after treatment (p ≤ 0.001) (T2) and at the 2-week (T3) follow-up (p ≤ 0.001), with self-efficacy only showing significant differences between groups 2 weeks after the treatment (p = 0.01) (T2). There were no differences between groups when comparing pain catastrophising at any time.
Conclusion: Whole-body PBM resulted in a significant reduction in pain and an improvement in quality of life in those participants suffering from FM after receiving 4 weeks of treatment. Furthermore, psychological factors such as kinesiophobia and self-efficacy were also improved. Thus, a whole-body PBM treatment is presented as a possible new multifactorial treatment with potential benefits for those with FM and more studies are needed to corroborate our findings.
Trial Registration: ClinicalTrials.gov (NCT0424897).
(© 2022. The Author(s).)
References: Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL, et al. 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum Semin Arthritis Rheum. 2016;46:319–29. (PMID: 10.1016/j.semarthrit.2016.08.012)
Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL, et al. AAPT diagnostic criteria for fibromyalgia. J Pain. 2019;20:611–28. (PMID: 10.1016/j.jpain.2018.10.008)
Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, et al. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat. 2012;2012.
Mas AJ, Carmona L, Valverde M, Ribas B, Navarro F, Ortiz AM, et al. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a natiowide study in Spain. Clin Exp Rheumatol. 2008;26:519–26.
Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17.
Vos T, Abajobir AA, Abbafati C, Abbas KM, Abate KH, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–59. (PMID: 10.1016/S0140-6736(17)32154-2)
Clauw DJ. Fibromyalgia: a clinical review. JAMA J Am Med Assoc. 2014;311:1547–55. (PMID: 10.1001/jama.2014.3266)
García-Ríos MC, Navarro-Ledesma S, Tapia-Haro RM, Toledano-Moreno S, Casas-Barragán A, Correa-Rodríguez M, et al. Effectiveness of health education in patients with fibromyalgia: a systematic review. Eur J Phys Rehabil Med. 2019;55:301–13. (PMID: 10.23736/S1973-9087.19.05524-2)
Sosa-Reina MD, Nunez-Nagy S, Gallego-Izquierdo T, Pecos-Martín D, Monserrat J, Álvarez-Mon M. Effectiveness of therapeutic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomized clinical trials. Biomed Res Int. 2017;2017.
Yeh SW, Hong CH, Shih MC, Tam KW, Huang YH, Kuan YC. Low-level laser therapy for fibromyalgia: a systematic review and meta-analysis. Pain Physician. 2019;22:241–54.
Salehpour F, Mahmoudi J, Kamari F, Sadigh-eteghad S, Rasta H, Hamblin MR, et al. Brain photobiomodulation therapy: a narrative review. Mol Neurobiol. 2019;55:6601–36. (PMID: 10.1007/s12035-017-0852-4)
Karu TI, Pyatibrat LV, Kolyakov SF, Afanasyeva NI. Absorption measurements of a cell monolayer relevant to phototherapy: reduction of cytochrome c oxidase under near IR radiation. J Photochem Photobiol B. 2005;81:98–106. (PMID: 10.1016/j.jphotobiol.2005.07.002)
Galvez-Sánchez CM, Reyes del Paso GA, Duschek S. Cognitive impairments in fibromyalgia syndrome: associations with positive and negative affect, alexithymia, pain catastrophizing and self-esteem. Front Psychol. 2018;9.
Galvez-Sánchez CM, Duschek S, Reyes GA. Psychological impact of fibromyalgia. Psychol Res Behav Manag. 2019;12:117–27. (PMID: 10.2147/PRBM.S178240)
Gur A, Karakoc M, Cevik R, Nas K, Sarac AJ, Karakoc M. Efficacy of low power laser therapy and exercise on pain and functions in chronic low back pain. Lasers Surg Med. 2003;32:233–8. (PMID: 10.1002/lsm.10134)
Honda Y, Sakamoto J, Hamaue Y, Kataoka H, Kondo Y, Sasabe R, et al. Effects of physical-agent pain relief modalities for fibromyalgia patients: a systematic review and meta-analysis of randomized controlled trials. Pain Res Manag. 2018;2018.
Kisselev SB, Moskvin SV. The use of laser therapy for patients with fibromyalgia: a critical literary review. J Lasers Med Sci. 2019;10:12–20. (PMID: 10.15171/jlms.2019.02)
Siracusa R, Di Paola R, Cuzzocrea S, Impellizzeri D. Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci. 2021.
Ghigiarelli JJ, Fulop AM, Burke AA, Ferrara AJ, Sell KM, Gonzalez AM, et al. The effects of whole-body photobiomodulation light-bed therapy on creatine kinase and salivary interleukin-6 in a sample of trained males: a randomized, crossover study. Front Sports Act Living. 2020;2:1–13. (PMID: 10.3389/fspor.2020.00048)
Navarro-Ledesma S, Gonzalez-Muñoz A, Carroll J, Burton P. Short- and long-term effects of whole-body photobiomodulation on pain, functionality, tissue quality, central sensitisation and psychological factors in a population suffering from fibromyalgia: protocol for a triple-blinded randomised clinical trial. Ther Adv Chronic Dis. 2022;13:204062232210780. (PMID: 10.1177/20406223221078095)
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63:e1-37. (PMID: 10.1016/j.jclinepi.2010.03.004)
Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. Pilot Feasibility Stud. 2016;2:1–32. https://doi.org/10.1186/s40814-016-0105-8 . (PMID: 10.1186/s40814-016-0105-8)
Hamblin MR, Huang YY, Sharma SK, Carroll J. Biphasic dose response in low level light therapy—an update. Dose-Response. 2011;9:602–18.
Jensen MP, Turner JA, Romano JM, Fisher LD. Comparative reliability and validity of chronic pain intensity measures. Pain. 1999;83:157–62. (PMID: 10.1016/S0304-3959(99)00101-3)
Shmueli A. The visual analogy rating scale of health-related quality of life: an examination of end-digit preferences. Health Qual Life Outcomes. 2005;3:2–6. (PMID: 10.1186/1477-7525-3-71)
Mannerkorpi K, Hernelid C. Leisure time physical activity instrument and physical activity at home and work instrument. Development, face validity, construct validity and test-retest reliability for subjects with fibromyalgia. Disabil Rehabil. 2005;27:695–701. (PMID: 10.1080/09638280400009063)
Darnall BD, Sturgeon JA, Cook KF, Taub CJ, Roy A, Burns JW, et al. Development and validation of a daily pain catastrophizing scale. J Pain. 2017;18:1139–49. (PMID: 10.1016/j.jpain.2017.05.003)
Navarro-Ledesma S, Gonzalez-Muñoz A, Carroll J, Burton P. Short- and long-term effects of whole-body photobiomodulation on pain, functionality, tissue quality, central sensitisation and psychological factors in a population suffering from fibromyalgia: protocol for a triple-blinded randomised clinical trial. Ther Adv Chronic Dis. 2022;13.
Gómez-Pérez L, López-Martínez AE, Ruiz-Párraga GT. Psychometric properties of the spanish version of the Tampa Scale for Kinesiophobia (TSK). J Pain. 2011;12:425–35. (PMID: 10.1016/j.jpain.2010.08.004)
Larsson C, Hansson EE, Sundquist K, Jakobsson U. Kinesiophobia and its relation to pain characteristics and cognitive affective variables in older adults with chronic pain. BMC Geriatr. 2016;1–7.
Salvador EMES, Franco KFM, Miyamoto GC, Franco YRDS, Cabral CMN. Analysis of the measurement properties of the Brazilian-Portuguese version of the Tampa Scale for Kinesiophobia-11 in patients with fibromyalgia. Braz J Phys Ther Revista Brasileira de Fisioterapia. 2021;25:168–74. (PMID: 10.1016/j.bjpt.2020.05.004)
Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1997;84:191–215. (PMID: 10.1037/0033-295X.84.2.191)
Jurado M del MM, Pérez-Fuentes M del C, Ruiz NFO, Márquez MDMS, Linares JJG. Self-efficacy and emotional intelligence as predictors of perceived stress in nursing professionals. Medicina (Lithuania). 2019;55.
López-Roig S, Pastor-Mira MÁ, Núñez R, Nardi A, Ivorra S, León E, et al. Assessing self-efficacy for physical activity and walking exercise in women with fibromyalgia. Pain Manag Nurs. 2021;22:571–8. (PMID: 10.1016/j.pmn.2021.05.007)
J C. Statistical power analysis for the behavioral sciences, 2nd edn. Hillsdale: Lawrence Erlbaum Associates; 1988. p. 1390.
Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149–58. (PMID: 10.1016/S0304-3959(01)00349-9)
Bourgault P, Lacasse A, Marchand S, Courtemanche-Harel R, Charest J, Gaumond I, et al. Multicomponent interdisciplinary group intervention for self-management of fibromyalgia: a mixed-methods randomized controlled trial. PLoS ONE. 2015;10:1–26. (PMID: 10.1371/journal.pone.0126324)
Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9:105–21. (PMID: 10.1016/j.jpain.2007.09.005)
Cheng K, Martin LF, Slepian MJ, Patwardhan AM, Ibrahim MM. Mechanisms and pathways of pain photobiomodulation: a narrative review. J Pain. 2021;22:763–77. (PMID: 10.1016/j.jpain.2021.02.005)
Vassão PG, de Souza ACF, da Silveira Campos RM, Garcia LA, Tucci HT, Renno ACM. Effects of photobiomodulation and a physical exercise program on the expression of inflammatory and cartilage degradation biomarkers and functional capacity in women with knee osteoarthritis: a randomized blinded study. Adv Rheumatol. 2021;61.
Logan RM, Al-Azri AR, Bossi P, Stringer AM, Joy JK, Soga Y, et al. Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2020;28:2485–98. (PMID: 10.1007/s00520-019-05170-9)
Camolesi GCV, Marichalar-Mendía X, Padín-Iruegas ME, Spanemberg JC, López-López J, Blanco-Carrión A, et al. Efficacy of photobiomodulation in reducing pain and improving the quality of life in patients with idiopathic burning mouth syndrome. A systematic review and meta-analysis. Lasers Med Sci. 2022:2123–33.
Gross AR, Dziengo S, Boers O, Goldsmith CH, Graham N, Lilge L, et al. Low level laser therapy (LLLT) for neck pain: a systematic review and meta-regression. Open Orthop J. 2013;7:396–419. (PMID: 10.2174/1874325001307010396)
Tripodi N, Feehan J, Husaric M, Sidiroglou F, Apostolopoulos V. The effect of low-level red and near-infrared photobiomodulation on pain and function in tendinopathy: a systematic review and meta-analysis of randomized control trials. BMC Sports Sci Med Rehabil. 2021;13:1–13. (PMID: 10.1186/s13102-021-00306-z)
Sobral APT, Sobral SDS, Campos TM, Horliana ACRT, Fernandes KPS, Bussadori SK, et al. Photobiomodulation and myofascial temporomandibular disorder: systematic review and meta-analysis followed by cost-effectiveness analysis. J Clin Exp Dent. 2021;13:e724–32. (PMID: 10.4317/jced.58084)
Neto FCJ, Martimbianco ALC, de Andrade RP, Bussadori SK, Mesquita-Ferrari RA, Fernandes KPS. Effects of photobiomodulation in the treatment of fractures: a systematic review and meta-analysis of randomized clinical trials. Lasers Med Sci. 2020;35:513–22. (PMID: 10.1007/s10103-019-02779-4)
Yang M, Yang Z, Wang P, Sun Z. Current application and future directions of photobiomodulation in central nervous diseases. Neural Regen Res. 2021;16:1177–85. (PMID: 10.4103/1673-5374.300486)
Liebert A, Bicknell B, Johnstone DM, Gordon LC, Kiat H, Hamblin MR. “Photobiomics”: can light, including photobiomodulation, alter the microbiome? Photobiomodul Photomed Laser Surg. 2019;37:681–93. (PMID: 10.1089/photob.2019.4628)
Tomazoni SS, Almeida MO, Bjordal JM, Stausholm MB, Machado CDSM, Leal-Junior ECP, et al. Photobiomodulation therapy does not decrease pain and disability in people with non-specific low back pain: a systematic review. J Physiother. 2020;66:155–65. (PMID: 10.1016/j.jphys.2020.06.010)
Passarella S, Casamassima E, Molinari S, Pastore D, Quagliariello E, Catalano IM, et al. Increase of proton electrochemical potential and ATP synthesis in rat liver mitochondria irradiated in vitro by helium-neon laser. FEBS Lett. 1984;175:95–9. (PMID: 10.1016/0014-5793(84)80577-3)
Poyton RO, Ball KA. Therapeutic photobiomodulation: nitric oxide and a novel function of mitochondrial cytochrome c oxidase. Discov Med. 2011;11:154–9.
Chung H, Dai T, Sharma SK, Huang Y-Y, Carrol JD, Hamblin MR. The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng. 2012;40:516–33. (PMID: 10.1007/s10439-011-0454-7)
Antonialli FC, De Marchi T, Tomazoni SS, Vanin AA, dos Santos GV, de Paiva PRV, et al. Phototherapy in skeletal muscle performance and recovery after exercise: effect of combination of super-pulsed laser and light-emitting diodes. Lasers Med Sci. 2014;29:1967–76. (PMID: 10.1007/s10103-014-1611-7)
Jonsjö MA, Åström J, Jones MP, Karshikoff B, Lodin K, Holmström L, et al. Patients with ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) and chronic pain report similar level of sickness behavior as individuals injected with bacterial endotoxin at peak inflammation. Brain Behav Immun Health. 2019;100028.
فهرسة مساهمة: Keywords: Chronic pain; Fibromyalgia; Kinesiophobia; Pain; Pain catastrophising; Photobiomodulation; Psychological factors; Quality of life; Self-efficacy
سلسلة جزيئية: ClinicalTrials.gov NCT0424897
تواريخ الأحداث: Date Created: 20221112 Latest Revision: 20230404
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9845459
DOI: 10.1007/s40122-022-00450-5
PMID: 36369323
قاعدة البيانات: MEDLINE
الوصف
تدمد:2193-8237
DOI:10.1007/s40122-022-00450-5